Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-04FDMT144David Kirn plan to sell securities of 4D Molecular Therapeutics, Inc. under Form 144MEDIUM
David Kirn filed Form 144 to notify SEC of plan to sell 26842 units of 4D Molecular Therapeutics, Inc. securities around 2026-08-04, with aggregate market value of $275,398.92. The total outstanding units is 52276254.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in pa...
Small CapBiotechnology
2026-08-04AGIO144SARAH GHEUENS plan to sell securities of AGIOS PHARMACEUTICALS, INC. under Form 144MEDIUM
SARAH GHEUENS filed Form 144 to notify SEC of plan to sell 30000 units of AGIOS PHARMACEUTICALS, INC. securities around 2026-08-04, with aggregate market value of $914,283.00. The total outstanding units is 59701882.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in pas...
Small CapBiotechnology
2026-08-04ARVN144NOAH C BERKOWITZ plan to sell securities of ARVINAS, INC. under Form 144MEDIUM
NOAH C BERKOWITZ filed Form 144 to notify SEC of plan to sell 30000 units of ARVINAS, INC. securities around 2026-08-04, with aggregate market value of $264,000.00. The total outstanding units is 64521198.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months ...
Small CapBiotechnology